Pharma BD Deal Intelligence

Roche Holding AG / IQuum, Inc.

2014 · Acquisition/Merger · $450M · Complete

Announcement Sentiment

Strongly positive

Roche acquired Massachusetts-based IQuum for $275M upfront plus up to $175M in product-related milestones, securing the Liat lab-in-a-tube system for point-of-care molecular diagnostics. The deal extended Roche's leadership in molecular diagnostics into the decentralized testing setting.

Did it work? Outcome assessment

Strategic verdict

Achieved Stated Rationale

Financial impact

Accretive

Pipeline outcome

Assets Advanced

Assessment window: 10yr post-close.

Key facts

Announced Apr 07, 2014
Closed Apr 22, 2014
Deal value $450M
Deal type Acquisition/Merger
Therapeutic area Infectious disease point-of-care diagnostics
Indications Infectious disease point-of-care diagnostics
Key assets Liat point-of-care molecular diagnostic system
Mechanism Lab-in-a-tube real-time PCR for rapid molecular testing

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals